Dr. Reddy’s tells Delhi High Court it will manufacture and export, but not sell, Ozempic-like drug in India in Novo Nordisk's Suit

The undertaking was given in a suit filed by Novo Nordisk alleging that Dr. Reddy’s and its affiliate have infringed its ozempic patent.
Delhi High Court
Delhi High Court
Published on
3 min read

The Delhi High Court on May 29 recorded an undertaking from Dr. Reddy’s Laboratories that it will not sell the Ozempic like drug in India, amid an ongoing patent infringement suit filed by Novo Nordisk A/S over the patent of blockbuster diabetes medication.

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com